Colgate-Palmolive Company $CL Shares Bought by Czech National Bank

Czech National Bank raised its position in Colgate-Palmolive Company (NYSE:CL) by 3.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 212,548 shares of the company’s stock after buying an additional 7,276 shares during the period. Czech National Bank’s holdings in Colgate-Palmolive were worth $16,796,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of CL. Vermillion & White Wealth Management Group LLC grew its position in shares of Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after acquiring an additional 155 shares during the period. Copia Wealth Management acquired a new position in Colgate-Palmolive in the 3rd quarter worth about $29,000. Cloud Capital Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter worth about $30,000. Global Wealth Strategies & Associates boosted its position in Colgate-Palmolive by 300.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after purchasing an additional 300 shares in the last quarter. Finally, Grove Bank & Trust grew its holdings in Colgate-Palmolive by 182.6% in the fourth quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after purchasing an additional 263 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft boosted their price objective on Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. UBS Group boosted their price target on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Citigroup upped their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Finally, Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a report on Sunday, February 1st. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Insider Buying and Selling at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares in the company, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the sale, the insider directly owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 184,683 shares of company stock valued at $17,486,693 over the last ninety days. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Stock Performance

NYSE CL opened at $84.08 on Friday. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The stock’s 50 day simple moving average is $91.12 and its 200-day simple moving average is $83.38. The company has a market cap of $67.77 billion, a PE ratio of 32.09, a price-to-earnings-growth ratio of 3.83 and a beta of 0.28. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.91 earnings per share. As a group, equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive’s payout ratio is currently 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.